Cotinine as a Biomarker of Environmental Tobacco Smoke Exposure

A biomarker is desirable in quantitating systemic exposure both in smokers and nonsmokers to constituents of tobacco smoke. Self-report measures in smokers, such as cigarettes smoked per day, are highly imprecise owing to individual differences in how cigarettes are smoked, with ranges of nicotine intake per cigarette from 0.3 to 3.0 mg (1, 2). Self-report measures, such as hours per day exposed to environmental tobacco smoke (ETS) by nonsmokers, are also likely to be imprecise indicators of intake of tobacco smoke owing to variations in the number of cigarettes smoked, proximity of nonsmokers to smokers, room ventilation and other environmental characteristics, as well as individual differences in sensitivity to and/or concern about adverse effects of ETS. The optimal assessment of exposure to tobacco smoke would be by analysis of the concentrations of a component of smoke in the body fluids of an exposed individual— i.e., a biologic marker or biomarker. There are two broad questions that need to be considered in assessing the validity of a biomarker of tobacco smoke exposure. The first is how well does the concentration of a marker chemical in the air reflect exposure to toxic constituents of smoke that are of concern? The second is how well does a concentration of a particular chemical in a biologic fluid reflect an individual's intake of that chemical (or a related chemical) from tobacco smoke? The National Research Council (3) has proposed criteria for a valid marker of ETS in the air as follows: The marker 1) should be unique or nearly unique for ETS so that other sources are minor in comparison; 2) should be easily detectable; 3) should be emitted at similar rates for a variety of tobacco products; and 4)